Get Real Time Here
| Open4.600 | Close4.870 |
| Vol / Avg.403.275K / 488.546K | Mkt Cap467.162M |
| Day Range4.530 - 5.000 | 52 Wk Range1.400 - 6.990 |
Gracell Biotechnologies Stock (NASDAQ:GRCL), Quotes and News Summary
Gracell Biotechnologies Stock (NASDAQ: GRCL) stock price, news, charts, stock research, profile.
| Open4.600 | Close4.870 |
| Vol / Avg.403.275K / 488.546K | Mkt Cap467.162M |
| Day Range4.530 - 5.000 | 52 Wk Range1.400 - 6.990 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.200 | -0.100 | 0.1000 | ||||
| REV | 0 |
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.370 | -0.300 | 0.0700 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-11-27 | Evercore ISI Group | Jonathan Miller | Initiates Coverage On | Outperform | - | - | - |
| 2023-10-19 | Stifel | Benjamin Burnett | Initiates Coverage On | Buy | Announces | - | 11.00 |
| 2023-09-05 | Cantor Fitzgerald | Louise Chen | Reiterates | OverweightOverweight | Maintains | - | 20.00 |
| 2023-08-30 | Cantor Fitzgerald | Louise Chen | Reiterates | OverweightOverweight | Maintains | - | 20.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| GRCL | Gracell Biotechnologies | 7.51% | 467.2M |
| MGNX | Macrogenics | 7.45% | 501.2M |
| SPRY | ARS Pharmaceuticals | 0% | 460.8M |
| ORTX | Orchard Therapeutics | 0% | 368.7M |
| BLUE | bluebird bio | -0.26% | 420.9M |
How do I buy Gracell Biotechnologies (GRCL) stock?
You can purchase shares of Gracell Biotechnologies (NASDAQ: GRCL) through any online brokerage.
Who are Gracell Biotechnologies's (GRCL) competitors?
Other companies in Gracell Biotechnologies’s space includes: Macrogenics (NASDAQ:MGNX), ARS Pharmaceuticals (NASDAQ:SPRY), Orchard Therapeutics (NASDAQ:ORTX), bluebird bio (NASDAQ:BLUE) and LianBio (NASDAQ:LIAN).
What is the target price for Gracell Biotechnologies (GRCL) stock?
The latest price target for Gracell Biotechnologies (NASDAQ: GRCL) was reported by Evercore ISI Group on Monday, November 27, 2023. The analyst firm set a price target for 0.00 expecting GRCL to fall to within 12 months (a possible -100.00% downside). 12 analyst firms have reported ratings in the last year.
Current Stock Price for Gracell Biotechnologies (GRCL)?
The stock price for Gracell Biotechnologies (NASDAQ: GRCL) is $4.87 last updated November 30, 2023 at 9:02 PM UTC.
Does Gracell Biotechnologies (GRCL) pay a dividend?
There is no dividend information for Gracell Biotechnologies.
When is Gracell Biotechnologies (NASDAQ:GRCL) reporting earnings?
Gracell Biotechnologies’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Gracell Biotechnologies (GRCL) going to split?
There is no upcoming split for Gracell Biotechnologies.
What sector and industry does Gracell Biotechnologies (GRCL) operate in?
Gracell Biotechnologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.